|
|
Biography |
|
|
Dr. Morris S. Berrie is Co-Chair of Tech Transfer Summit Ltd. and Managing Director of Tech Investor Ltd. The former is an organization that globally facilitates deal flow in the early stage/SME biotech sector whilst the latter specifically aids and advises governments, regions and companies throughout the biotech sector on “the business of science”, i.e. strategic business development and capital raising. Previously he was the Chief Executive Officer and Editor-in-Chief of the “Biotechnology Investment Today Group” where he worked with prestigious clients. Prior to that he was Head of Global Intelligence and Business Development for Nature Publishing Group and before that the Compound Director of the Life Science patent and drug registry content of the Investigational Drug database (IDdb) owned by Thomson Reuters. He has worked at Schering AG, is a Chartered Chemist, a Member of the Royal Society of Chemistry and was the recipient of an European DG Post-Doctoral Fellowship upon completing his Ph.D. at Imperial College, London. He also holds a seat at the Business Strategy, Publishing and Awards Committees of the Society of Chemical Industry.
|
|
|
|
|
|
|
Abstract |
|
|
|
|
|
|
|
|
|
|
|